| RS2524691724 |
DCX
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2524694574 |
COL11A1
|
Health Risk |
Likely pathogenic |
COL11A1-related disorder, COL11A1-related disorder |
| RS2524697578 |
MUTYH
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2524698132 |
DRAM2
|
Health Risk |
Pathogenic |
— |
| RS2524698413 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2524698721 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2524698808 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524699309 |
AGL
|
Health Risk |
Pathogenic |
— |
| RS2524699538 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524699735 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524700617 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524700686 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524707695 |
DHDDS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 59, Developmental delay and seizures with or without movement abnormalities |
| RS2524708025 |
DHDDS
|
Health Risk |
Pathogenic |
Developmental delay and seizures with or without movement abnormalities, Retinitis pigmentosa 59 |
| RS2524708485 |
DHDDS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2524720199 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524720459 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524721125 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524724346 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524724626 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524724887 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524726100 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2524730915 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524730925 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524731035 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524731141 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524731280 |
KCNN3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2524731355 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524731432 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524731921 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524732108 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524732400 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524732551 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524732601 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524732639 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524732783 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524733814 |
SCP2
|
Health Risk |
Likely pathogenic |
— |
| RS2524746325 |
DRAM2
|
Health Risk |
Pathogenic |
— |
| RS2524757114 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524757369 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524757411 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524757462 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524757648 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524760741 |
KCNA3
|
Health Risk |
Likely pathogenic |
KCNA3-associated developmental and epileptic encephalopathy, KCNA3-associated developmental and epileptic encephalopathy |
| RS2524761160 |
KCNA3
|
Health Risk |
Likely pathogenic |
KCNA3-associated developmental and epileptic encephalopathy, KCNA3-associated developmental and epileptic encephalopathy |
| RS2524761170 |
KCNA3
|
Health Risk |
Likely pathogenic |
KCNA3-associated disorder, KCNA3-associated developmental and epileptic encephalopathy |
| RS2524761189 |
KCNA3
|
Health Risk |
Likely pathogenic |
KCNA3-associated developmental and epileptic encephalopathy, KCNA3-associated developmental and epileptic encephalopathy |
| RS2524761194 |
KCNA3
|
Health Risk |
Likely pathogenic |
KCNA3-associated developmental and epileptic encephalopathy, KCNA3-associated developmental and epileptic encephalopathy |
| RS2524761198 |
KCNA3
|
Health Risk |
Likely pathogenic |
KCNA3-associated developmental and epileptic encephalopathy, KCNA3-associated developmental and epileptic encephalopathy |
| RS2524761275 |
KCNA3
|
Health Risk |
Likely pathogenic |
KCNA3-associated developmental and epileptic encephalopathy, KCNA3-associated developmental and epileptic encephalopathy |
| RS2524761374 |
KCNA3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, KCNA3-associated developmental and epileptic encephalopathy |
| RS2524761478 |
KCNA3
|
Health Risk |
Likely pathogenic |
KCNA3-associated developmental and epileptic encephalopathy, KCNA3-associated developmental and epileptic encephalopathy |
| RS2524761872 |
KCNA3
|
Health Risk |
Likely pathogenic |
KCNA3-associated developmental and epileptic encephalopathy, KCNA3-associated developmental and epileptic encephalopathy |
| RS2524761885 |
KCNA3
|
Health Risk |
Likely pathogenic |
KCNA3-associated developmental and epileptic encephalopathy, KCNA3-associated developmental and epileptic encephalopathy |
| RS2524774440 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2524777893 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2524782520 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2524790740 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2524792669 |
COL11A1
|
Health Risk |
Likely pathogenic |
COL11A1-related disorder, COL11A1-related disorder |
| RS2524793782 |
UBAP2L
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with impaired language, behavioral abnormalities |
| RS2524802526 |
TOE1
|
Health Risk |
Likely pathogenic |
TOE1-related disorder, TOE1-related disorder |
| RS2524804604 |
PIK3CD
|
Health Risk |
Likely pathogenic |
Immunodeficiency 14b, autosomal recessive |
| RS2524805817 |
PIK3CD
|
Health Risk |
Likely pathogenic |
Immunodeficiency 14b, autosomal recessive |
| RS2524811532 |
PIK3CD
|
Health Risk |
Likely pathogenic |
Immunodeficiency 14, Immunodeficiency 14 |
| RS2524814230 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS2524815453 |
PIK3CD
|
Health Risk |
Pathogenic |
Immunodeficiency 14, Immunodeficiency 14 |
| RS2524820366 |
GBA1
|
Health Risk |
Pathogenic |
— |
| RS2524820658 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS2524821657 |
SLC35D1
|
Health Risk |
Pathogenic |
Schneckenbecken dysplasia, Schneckenbecken dysplasia |
| RS2524822421 |
SLC35D1
|
Health Risk |
Pathogenic |
Schneckenbecken dysplasia, Schneckenbecken dysplasia |
| RS2524831565 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS2524831647 |
GBA1
|
Health Risk |
Pathogenic |
— |
| RS2524834596 |
DCX
|
Health Risk |
Pathogenic |
— |
| RS2524835526 |
DCX
|
Health Risk |
Likely pathogenic |
Lissencephaly type 1 due to doublecortin gene mutation, Lissencephaly type 1 due to doublecortin gene mutation |
| RS2524836385 |
DCX
|
Health Risk |
Likely pathogenic |
— |
| RS2524837524 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS2524839442 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gaucher disease type I, Gaucher disease type I |
| RS2524842577 |
PIK3CD
|
Health Risk |
Pathogenic |
Immunodeficiency 14, Immunodeficiency 14 |
| RS2524844480 |
GBA1
|
Health Risk |
Likely pathogenic |
Gaucher disease type I, Gaucher disease type I |
| RS2524844959 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS2524846674 |
CSDE1
|
Health Risk |
Likely pathogenic |
— |
| RS2524846772 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2524846900 |
GBA1
|
Health Risk |
Pathogenic |
— |
| RS2524847096 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS2524847177 |
CSDE1
|
Health Risk |
Pathogenic |
— |
| RS2524851054 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS2524851566 |
GBA1
|
Health Risk |
Likely pathogenic |
Gaucher disease, Gaucher disease |
| RS2524852698 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524853377 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS2524853993 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524854159 |
ATP1A2
|
Health Risk |
Likely pathogenic |
ATP1A2-related disorder, ATP1A2-related disorder |
| RS2524856473 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS2524857158 |
ATP1A2
|
Health Risk |
Pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS2524857474 |
ATP1A2
|
Health Risk |
Pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS2524858642 |
DCX
|
Health Risk |
Likely pathogenic |
Lissencephaly type 1 due to doublecortin gene mutation, Lissencephaly type 1 due to doublecortin gene mutation |
| RS2524858685 |
DCX
|
Health Risk |
Likely pathogenic |
Lissencephaly type 1 due to doublecortin gene mutation, Lissencephaly type 1 due to doublecortin gene mutation |
| RS2524859237 |
DCX
|
Health Risk |
Likely pathogenic |
Lissencephaly type 1 due to doublecortin gene mutation, Lissencephaly type 1 due to doublecortin gene mutation |
| RS2524859328 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS2524859378 |
STIL
|
Health Risk |
Likely pathogenic |
— |
| RS2524865450 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |